Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021

/PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of...

Related Keywords

Germany ,Georgia ,United States ,Canada ,Atlanta ,American ,Soheil Meshinchi ,Sutro Biopharma ,Anniej Chang ,Quy Le ,Arturo Molina ,Contactmaggie Beller ,Sutro Xpress ,Fred Hutchinson Cancer Research Center On Sutro ,American Society Of Hematology Annual Meeting ,Celgene Corporation ,Nasdaq ,Prnewswire Sutro Biopharma Inc ,Exchange Commission ,Division Of Pediatric Hematology ,Merck Kga ,Sutro Biopharma Inc ,Meshinchi Lab ,Merck Kgaa ,University Of Washington School Medicine ,Serono ,Bristol Myers Squibb ,Fred Hutchinson Cancer Research Center ,American Society ,Hematology Annual Meeting ,Clinical Research Division ,Pediatric Hematology Oncology ,Washington School ,Staff Scientist ,Chief Medical Officer ,South San Francisco ,Orphan Drug Designation ,Fast Track ,Myers Squibb ,Private Securities Litigation Reform Act ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,